NAVI:NASDAQNavient Corporation Analysis
Data as of 2026-04-19 - not real-time
$8.87
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Navient trades at a forward P/E of 9.4, well below the industry average of 17.7, and a price‑to‑book of 0.35, suggesting a materially undervalued position despite a negative profit margin of -24% and a staggering debt‑to‑equity ratio above 1,900. The stock offers a headline dividend yield of 7.22%, but the payout ratio of 200% flags an unsustainable dividend policy, and cash flow coverage is weak given zero free cash flow. Technicals show the price hovering near the resistance level of 8.89 with a bullish MACD histogram (+0.096) and an RSI of 60, yet the broader trend is labeled bearish and volume is decreasing, underscoring heightened short‑term pressure.
The recent appointment of Board Chair Edward Bramson as CEO adds a potential catalyst for strategic realignment, but the company remains exposed to high regulatory scrutiny in the student‑loan sector, elevated volatility (32% 30‑day) and a beta around 1.0. Given the mix of deep discount valuation, leadership transition, and pronounced risk factors, investors should treat NAVI as a high‑risk, value‑oriented play with limited upside unless the turnaround narrative gains traction.
The recent appointment of Board Chair Edward Bramson as CEO adds a potential catalyst for strategic realignment, but the company remains exposed to high regulatory scrutiny in the student‑loan sector, elevated volatility (32% 30‑day) and a beta around 1.0. Given the mix of deep discount valuation, leadership transition, and pronounced risk factors, investors should treat NAVI as a high‑risk, value‑oriented play with limited upside unless the turnaround narrative gains traction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near resistance with bearish trend direction
- High dividend yield but unsustainable payout
- Decreasing volume and elevated volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to peers
- Leadership transition offering potential operational improvements
- Forward P/E below industry average indicating upside potential
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Heavy debt load and negative earnings
- Persistent regulatory risk in the student‑loan market
- Potential for dividend policy adjustment if cash flow improves
Key Metrics & Analysis
Financial Health
Revenue Growth-54.90%
Profit Margin-24.24%
P/E Ratio9.4
ROE-3.17%
ROA-0.16%
Debt/Equity1908.50
P/B Ratio0.4
Op. Cash Flow$441.0M
Industry P/E17.7
Technical Analysis
TrendBearish
RSI60.1
Support$7.80
Resistance$8.89
MA 20$8.28
MA 50$8.65
MA 200$11.78
MACDBullish
VolumeDecreasing
Fear & Greed Index90.21
Valuation
Target Price$9.00
Upside/Downside1.47%
GradeUndervalued
TypeValue
Dividend Yield7.22%
Risk Assessment
Beta1.02
Volatility32.10%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.